86 related articles for article (PubMed ID: 27487715)
1. [Intravitreal Triamcinolone Acetonide for Persistent Diabetic Macular Edema after Vitrectomy].
Ichio A; Sugimoto M; Kondo M
Nippon Ganka Gakkai Zasshi; 2016 Jun; 120(6):429-38. PubMed ID: 27487715
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema After Vitrectomy.
Watanabe A; Tsuzuki A; Arai K; Gekka T; Kohzaki K; Tsuneoka H
J Ocul Pharmacol Ther; 2016; 32(1):38-43. PubMed ID: 26325253
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
6. Deferred intravitreal triamcinolone in diabetic eyes after phacoemulsification.
Campos A; Beselga D; Mendes S; Campos J; Neves A; Sousa P
J Ocul Pharmacol Ther; 2014 Nov; 30(9):717-28. PubMed ID: 25111757
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
Fan C; Wang Y; Ji Q; Zhao B; Xie J
Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755
[TBL] [Abstract][Full Text] [Related]
11. Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.
Koga T; Mawatari Y; Inumaru J; Fukushima M; Tanihara H
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1247-52. PubMed ID: 16021497
[TBL] [Abstract][Full Text] [Related]
12. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Bakri SJ; Larson TA
Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
[TBL] [Abstract][Full Text] [Related]
13. Treatment of branch retinal vein occlusion induced macular edema in treatment-naïve cases with a single intravitreal triamcinolone or bevacizumab injection.
Chen CH; Chen YH; Wu PC; Chen YJ; Lee JJ; Liu YC; Kuo HK
Chang Gung Med J; 2010; 33(4):424-35. PubMed ID: 20804672
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.
Doi N; Sakamoto T; Sonoda Y; Yasuda M; Yonemoto K; Arimura N; Uchino E; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):71-8. PubMed ID: 21853229
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of visual acuity and central macular thickness after vitrectomy for diffuse diabetic macular edema with or without preoperative treatments].
Nizawa T; Arai M; Takatsuna Y; Oshitari T; Sato E; Yamamoto S
Nippon Ganka Gakkai Zasshi; 2013 Oct; 117(10):785-92. PubMed ID: 24354262
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.
Kim JH; Kang SW; Ha HS; Kim JR
Korean J Ophthalmol; 2013 Jun; 27(3):186-93. PubMed ID: 23730111
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema.
Sonoda S; Sakamoto T; Yamashita T; Otsuka H; Shirasawa M; Kakiuchi N; Uchino E; Terasaki H; Kawano H
Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3979-85. PubMed ID: 24906857
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.
Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y
Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512
[TBL] [Abstract][Full Text] [Related]
20. The effects and safety of intravitreal triamcinolone injections in the treatment of diabetic macular edema.
Zając-Pytrus HM; Kaczmarek R; Strońska-Lipowicz D; Pomorska M; Misiuk-Hojło M
Adv Clin Exp Med; 2017; 26(1):45-49. PubMed ID: 28397431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
